Literature DB >> 24965990

Mid-pregnancy vitamin D levels and postpartum depression.

Esra Bahar Gur1, Ayse Gokduman2, Guluzar Arzu Turan3, Sumeyra Tatar3, Irem Hepyilmaz3, Esma Burcak Zengin4, Fatma Eskicioglu5, Serkan Guclu3.   

Abstract

OBJECTIVES: Postpartum depression (PPD) is a common disorder that affects 10-15% of postpartum women, and it can have negative effects on both the mother and newborn. Recent studies have suggested that low levels of vitamin D are associated with poor mood and depression. The aim of this prospective study was to evaluate a possible association between PPD and serum levels of 25-hydroxy vitamin D3 (25(OH)D3), a reliable measurement of vitamin D, during mid-pregnancy. STUDY
DESIGN: The source population consisted of all pregnant women between 24 and 28 gestational weeks from June 2012 to October 2012 at Bornova Health Research and Application Hospital, Sifa University. In order to better evaluate a possible effect between vitamin D levels and PPD, individuals with characteristics that put them at risk for developing PPD were excluded from the study. Serum 25(OH)D3 levels were evaluated mid-pregnancy in the study group. Serum 25(OH)D3 concentrations ≤20ng/mL (50nmol/L) were classified as a mild deficiency and those ≤10ng/mL (25nmol/L) were classified as a severe deficiency. Pregnant subjects having complications during birth or with the newborn after delivery were excluded from the study. The Edinburgh Postnatal Depression Scale (EPDS) was used to assess maternal PPD 1 week, 6 weeks, and 6 months after delivery. A Pearson correlation was used to measure the strength of the associations between the EPDS scores and vitamin D levels analyzed during the three time periods. A logistic regression analysis was used to determine the independent effects of vitamin D on PPD.
RESULTS: Six hundred and eighty-seven pregnant women were included in this study. After excluding women due to PPD risk factors (in two stages), 179 pregnant women were screened for vitamin D levels during mid-pregnancy and in the 6th month postpartum. Eleven percent of our study group had severe vitamin D deficiency and 40.3% had mild vitamin D deficiency. The frequency of PPD was 21.6% at the 1st week, 23.2% at 6th week, and 23.7% at the 6th month. There was a significant relationship between low 25(OH)D3 levels in mid-pregnancy and high EPDS scores, which is indicative of PPD for all three follow-up periods (p=0.003, p=0.004 and p<0.001, respectively). In addition, there was a significant negative correlation between vitamin D levels and EDPS at all three time points (r=-0.2, -0.2, -0.3, respectively).
CONCLUSIONS: Vitamin D deficiency in mid-pregnancy may be a factor affecting the development of PPD. More extensive studies are required to be carried out on this subject.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Postpartum depression; Pregnancy; Vitamin D levels

Mesh:

Substances:

Year:  2014        PMID: 24965990     DOI: 10.1016/j.ejogrb.2014.05.017

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  21 in total

1.  Vitamin D deficiency and depressive symptoms in pregnancy are associated with adverse perinatal outcomes.

Authors:  Eynav Elgavish Accortt; Amy Lamb; James Mirocha; Calvin J Hobel
Journal:  J Behav Med       Date:  2018-04-18

2.  Sleep, Anxiety, and Vitamin D Status and Risk for Peripartum Depression.

Authors:  Courtney E King; Allison Wilkerson; Roger Newman; Carol L Wagner; Constance Guille
Journal:  Reprod Sci       Date:  2022-03-29       Impact factor: 3.060

Review 3.  Immune System and Psychological State of Pregnant Women during COVID-19 Pandemic: Are Micronutrients Able to Support Pregnancy?

Authors:  Alessio Alesci; Simona Pergolizzi; Angelo Fumia; Anthea Miller; Caterina Cernigliaro; Maria Zaccone; Vanessa Salamone; Enza Mastrantonio; Sebastiano Gangemi; Giovanni Pioggia; Nicola Cicero
Journal:  Nutrients       Date:  2022-06-18       Impact factor: 6.706

4.  Lower prenatal vitamin D status and postpartum depressive symptomatology in African American women: Preliminary evidence for moderation by inflammatory cytokines.

Authors:  Eynav Elgavish Accortt; Christine Dunkel Schetter; Rosalind M Peters; Andrea E Cassidy-Bushrow
Journal:  Arch Womens Ment Health       Date:  2015-09-26       Impact factor: 3.633

5.  Shortening day length: a potential risk factor for perinatal depression.

Authors:  Deepika Goyal; Caryl Gay; Rosamar Torres; Kathryn Lee
Journal:  J Behav Med       Date:  2018-09-27

6.  Maternal Vitamin D Status and Its Related Factors in Pregnant Women in Bangkok, Thailand.

Authors:  Busadee Pratumvinit; Preechaya Wongkrajang; Tuangsit Wataganara; Sithikan Hanyongyuth; Akarin Nimmannit; Somruedee Chatsiricharoenkul; Kotchamol Manonukul; Kanit Reesukumal
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

7.  Vitamin D levels and perinatal depressive symptoms in women at risk: a secondary analysis of the mothers, omega-3, and mental health study.

Authors:  Jennifer Anne Williams; Vivian C Romero; Chelsea M Clinton; Delia M Vazquez; Sheila M Marcus; Julie L Chilimigras; Susan E Hamilton; Lucy J Allbaugh; Anjel M Vahratian; Ronald M Schrader; Ellen L Mozurkewich
Journal:  BMC Pregnancy Childbirth       Date:  2016-08-03       Impact factor: 3.007

Review 8.  Nutrients and perinatal depression: a systematic review.

Authors:  Thalia M Sparling; Robin C Nesbitt; Nicholas Henschke; Sabine Gabrysch
Journal:  J Nutr Sci       Date:  2017-12-20

9.  The Association between Vitamin D and Health-Related Quality of Life in Korean Adults.

Authors:  Ji Sun Kim; Young Eun Choi; Jin Kyung Baek; Ho Jin Cho; Ye Seul Kim
Journal:  Korean J Fam Med       Date:  2016-07-21

10.  Low Prenatal Vitamin D Metabolite Ratio and Subsequent Postpartum Depression Risk.

Authors:  Eynav E Accortt; Chander Arora; James Mirocha; Susan Jackman; Richard Liang; S Ananth Karumanchi; Anders H Berg; Calvin J Hobel
Journal:  J Womens Health (Larchmt)       Date:  2020-10-06       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.